Attovia Therapeutics insider reports stock and options
Attovia Therapeutics, Inc. reported initial beneficial ownership for its President and CEO role, consisting of common stock and stock options.
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. reported initial beneficial ownership for its President and CEO role, consisting of common stock and stock options. Direct holdings include 87,843 shares of Common Stock. The reporting person also has indirect ownership of additional common shares held through three trusts for which the reporting person serves as trustee or co-trustee.
Unexercised stock options to acquire Common Stock include: an option over 23,437 shares at an exercise price of $1.5793 per share expiring on August 16, 2033; an option over 409,709 shares at $3.5302 per share expiring on May 8, 2034; and an option over 370,290 shares at $4.9237 per share expiring on May 17, 2035. Each option vests 25% on the one-year anniversary of its grant date (June 2, 2023; May 9, 2024; and May 18, 2025, respectively), with the remaining shares vesting in equal monthly installments over three years, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Attovia Therapeutics, Inc.
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F6 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 803,436 contracts (Direct);
Common Stock — 87,843 shares (Direct);
Common Stock — 460,709 shares (Indirect, By Trust)
Footnotes (6)
- F1. These shares are held by the TF 2025 Annuity Trust, of which the reporting person is the trustee.
- F2. These shares are held by the TF 2026 Annuity Trust, of which the reporting person is the trustee.
- F3. These shares are held by the Hai Fu Revocable Trust, of which the reporting person and Hai Fu are trustees.
- F4. Vest with respect to 25% of the shares of common stock underlying the stock option on the one-year anniversary of June 2, 2023, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service through such date.
- F5. Vest with respect to 25% of the shares of common stock underlying the stock option on the one-year anniversary of May 9, 2024, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service through such date.
- F6. Vest with respect to 25% of the shares of common stock underlying the stock option on the one-year anniversary of May 18, 2025, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service through such date.
Key Figures
Direct common stock holdings: 87,843 shares
Option underlying shares at $1.5793: 23,437 shares
Option underlying shares at $3.5302: 409,709 shares
+3 more
6 metrics
Direct common stock holdings
87,843 shares
Common Stock held directly following the reported holdings as of August 4, 2026
Option underlying shares at $1.5793
23,437 shares
Underlying Common Stock for option exercisable at $1.5793 expiring August 16, 2033
Option underlying shares at $3.5302
409,709 shares
Underlying Common Stock for option exercisable at $3.5302 expiring May 8, 2034
Option underlying shares at $4.9237
370,290 shares
Underlying Common Stock for option exercisable at $4.9237 expiring May 17, 2035
Initial vesting portion
25%
Portion of each stock option vesting on the one-year anniversary of its grant date
Remaining vesting period
3 years
Remaining option shares vest in equal monthly installments over three years
Key Terms
Stock Option (Right to Buy), Annuity Trust, Revocable Trust, beneficial ownership, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title "Stock Option (Right to Buy)" linked to Common Stock"
Annuity Trust financial
"These shares are held by the TF 2025 Annuity Trust, of which the reporting"
Revocable Trust financial
"These shares are held by the Hai Fu Revocable Trust, of which the reporting"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
beneficial ownership financial
"Form 3 reported initial beneficial ownership for common stock and options"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
vesting financial
"Vest with respect to 25% of the shares of common stock underlying"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Attovia Therapeutics (ATTO) disclose in this Form 3?
Attovia Therapeutics discloses initial beneficial ownership for its President and CEO role, including 87,843 common shares held directly and several stock option awards plus indirect holdings through three trusts.
What stock options are reported for Attovia Therapeutics (ATTO)?
Reported options cover 23,437 shares at $1.5793, 409,709 shares at $3.5302, and 370,290 shares at $4.9237 per share. These options are exercisable for Common Stock and have expirations in 2033, 2034, and 2035, respectively.
How do the Attovia Therapeutics (ATTO) options vest?
Each option vests 25% on the one-year anniversary of its grant date, with the remaining 75% vesting in equal monthly installments over three years, subject to the reporting person’s continued service through each vesting date.
What trusts are involved in the Attovia Therapeutics (ATTO) Form 3?
Indirect common stock holdings are reported as held by the TF 2025 Annuity Trust, TF 2026 Annuity Trust, and the Hai Fu Revocable Trust, for which the reporting person is trustee or co-trustee, indicating trust-based ownership.
Does this Attovia Therapeutics (ATTO) Form 3 show any stock sales or purchases?
No explicit buy or sell transactions are reported. The Form 3 presents existing holdings of common stock and stock options, rather than new market purchases or sales, consistent with an initial beneficial ownership statement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
